Last reviewed · How we verify

NCT06973980

HIIT in Sedentary Obese Adults: Effects on Metabolic Risk, Body Composition, and FABP4

Recruiting now NA Last updated 15 May 2025
What this trial tests

NA trial testing Exercise in High-Intensity Interval Training in 28 participants. Currently enrolling.

Timeline
1 March 2025
Primary endpoint
1 July 2025
1 September 2025

Quick facts

Lead sponsorEastern Mediterranean University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment28
Start date1 March 2025
Primary completion1 July 2025
Estimated completion1 September 2025
Sites1 location across Cyprus

Drugs / interventions tested

Conditions studied

Sponsor

Eastern Mediterranean University

Who can join

Adults 20 to 35, any sex, with High-Intensity Interval Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is aimed to investigate the responses of Fatty Acid Binding Protein 4 (FABP4), which has been discovered as a novel biomarker of obesity and metabolic diseases, to regular exercise training. The aim of this study is to investigate the effects of high-intensity interval training (HIIT) on cardiometabolic risk factors, body composition, and plasma FABP4 levels in sedentary obese adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for High-Intensity Interval Training

Currently open trials in the same condition.

Other Eastern Mediterranean University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06973980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing